Healthcare

Artrya (ASX:AYA) develops cloud-based tools that support clinicians assessing coronary artery disease from CCTA images. Its Salix offering includes Coronary Anatomy, which describes coronary structures, and Coronary Plaque, which assists with assessing plaque characteristics. Coronary Flow is a further product under development, subject to …

Actinogen Medical (ASX:ACW) concentrates its research and development on Xanamem, also known as emestedastat. The drug is designed to inhibit 11β-HSD1, an enzyme involved in producing cortisol within tissues, including the brain. It remains investigational and has not received marketing approval. Accordingly, the company’s …

Algorae Pharmaceuticals (ASX:1AI) operates AlgoraeRx and AlgoraeOS. AlgoraeRx sources generic and specialty medicines, negotiates licensing and supply agreements, manages regulatory registrations and targets institutional distribution in Australia and New Zealand. Its therapeutic categories include oncology, cardiovascular, metabolic and specialty care.

Alterity Therapeutics (ASX:ATH) is a Melbourne-based, clinical-stage biotechnology business with activities involving drug discovery, clinical trials and regulatory development. The company has not commercialised a medicine and therefore does not generate product-sales revenue. Its lead compound ATH434 is an oral investigational treatment designed to …

Amplia Therapeutics (ASX:ATX) is a clinical-stage pharmaceutical developer rather than a commercial supplier of approved cancer medicines. Its lead drug candidate, narmafotinib, also called AMP945, inhibits FAK, a protein implicated in tumour growth and the environment surrounding cancer cells. Clinical studies are testing whether …

Ansell (ASX:ANN) operates two reporting segments, Healthcare and Industrial. Healthcare encompasses surgical gloves, examination and single-use protection, and cleanroom products for hospitals, laboratories, pharmaceutical production and controlled manufacturing environments. The Industrial division supplies mechanical and chemical protection products to workplaces requiring resistance to cuts, …

Atomo Diagnostics (ASX:AT1) designs integrated rapid-testing devices combining sample collection, processing and result presentation. Its product activities include HIV self-tests, point-of-care tests and supply of diagnostic cassettes to industry partners. The Pascal platform supports tests developed by other manufacturers, while Atomo also works on …